Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) reports a Q2 loss of $0.04, versus the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE